European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.31% to 1,701.97 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and telecommunications firm Nokia (NOK), which rose 2.1% and 2%, respectively. They were followed by petroleum refiner Equinor (EQNR), which rose 1.2%.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and software company SAP (SAP), which lost 4.6% and 4.4% respectively. They were followed by internet browser company Opera (OPRA) and biopharmaceutical firm DBV Technologies (DBVT), which fell 4.3% and 4.1% respectively.

The gainers from the UK were led by oil and gas companies BP (BP) and Shell (SHEL), which advanced 2.1% and 1.5% respectively. They were followed by medical device maker Smith & Nephew (SNN) and biopharmaceutical company Amarin (AMRN), which increased 1.4% and 1.2% respectively.

The decliners from the UK and Ireland were led by Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which fell 5.9% and 4.3% respectively. They were followed by software firm Endava (DAVA) and Silence Therapeutics (SLN), which were down 3.6% and 2.3% respectively.